Adrenalectomy Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type I Who Had Somatic KCNJ5 Mutation.

作者: Yu-Fang Lin , Kang-Yung Peng , Chia-Hui Chang , Ya-Hui Hu , Vin-Cent Wu

DOI: 10.1210/JC.2019-00689

关键词:

摘要: CONTEXT Familial hyperaldosteronism type I (FH-I) or glucocorticoid-remediable aldosteronism (GRA) is caused by unequal crossing over of the steroid 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. Somatic KCNJ5 mutations have not been reported in patients with GRA; therefore, appropriate treatment prognosis such concurrent cases remain unknown. CASE DESCRIPTION Two siblings a Taiwanese family GRA were found to adrenal adenomas somatic mutations. Complete clinical cure was achieved after unilateral adrenalectomy. Furthermore, conversion site chimeric gene identified direct sequencing. CONCLUSIONS We report coexistence mutation GRA. Patients whose blood pressure management develops resistance glucocorticoid could therefore benefit from lateralization test. The promising outcomes adrenalectomy presented this offer new perspectives for further research into various PA subtypes.

参考文章(22)
J. C. Laidlaw, J. L. Ruse, D. J. A. Sutherland, Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone Canadian Medical Association Journal. ,vol. 95, pp. 1109- 1119 ,(1966)
L Pascoe, X Jeunemaitre, M C Lebrethon, K M Curnow, C E Gomez-Sanchez, J M Gasc, J M Saez, P Corvol, Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. Journal of Clinical Investigation. ,vol. 96, pp. 2236- 2246 ,(1995) , 10.1172/JCI118279
Graham T. McMahon, Robert G. Dluhy, Glucocorticoid-remediable aldosteronism. Cardiology in Review. ,vol. 12, pp. 44- 48 ,(2004) , 10.1097/01.CRD.0000096417.42861.CE
Michael Stowasser, Phillip R. Huggard, Tony R. Rossetti, Anthony W. Bachmann, Richard D. Gordon, Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I. The Journal of Clinical Endocrinology and Metabolism. ,vol. 84, pp. 4031- 4036 ,(1999) , 10.1210/JCEM.84.11.6159
Nan-Fang Li, Hong-Jian Li, De-Lian Zhang, Ju-Hong Zhang, Xiao-Guang Yao, Hong-Mei Wang, Suofeiya Abulikemu, Ke-Ming Zhou, Xiang-Yang Zhang, None, Genetic variations in the KCNJ5 gene in primary aldosteronism patients from Xinjiang, China. PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0054051
Michael Stowasser, Richard D. Gordon, Primary aldosteronism: learning from the study of familial varieties. Journal of Hypertension. ,vol. 18, pp. 1165- 1176 ,(2000) , 10.1097/00004872-200018090-00002
Michael Stowasser, Anthony W. Bachmann, Phillip R. Huggard, Tony R. Rossetti, Richard D. Gordon, Severity of Hypertension in Familial Hyperaldosteronism Type I: Relationship to Gender and Degree of Biochemical Disturbance1 The Journal of Clinical Endocrinology & Metabolism. ,vol. 85, pp. 2160- 2166 ,(2000) , 10.1210/JCEM.85.6.6651
Nina Queisser, Nicole Schupp, Helga Stopper, Reinhard Schinzel, Patricia I. Oteiza, Aldosterone increases kidney tubule cell oxidants through calcium-mediated activation of NADPH oxidase and nitric oxide synthase. Free Radical Biology and Medicine. ,vol. 51, pp. 1996- 2006 ,(2011) , 10.1016/J.FREERADBIOMED.2011.08.028
Paolo Mulatero, Silvia Monticone, William E. Rainey, Franco Veglio, Tracy Ann Williams, Role of KCNJ5 in familial and sporadic primary aldosteronism. Nature Reviews Endocrinology. ,vol. 9, pp. 104- 112 ,(2013) , 10.1038/NRENDO.2012.230
Nina Queisser, Kerstin Amann, Valentin Hey, Samy L. Habib, Nicole Schupp, Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo Free Radical Biology and Medicine. ,vol. 54, pp. 17- 25 ,(2013) , 10.1016/J.FREERADBIOMED.2012.10.549